Experimental Hematology
Volume 36, Issue 5 , Pages 533-534, May 2008

Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases

  • Bertrand Huard

      Affiliations

    • Corresponding Author InformationOffprint requests to: Bertrand Huard, Ph.D., Department of Pathology-Immunology, University Medical Center, Rue Michel Servet 1, 1211 Geneva 4, Switzerland

Institute of Pathology, University Hospital Basel, Basel, Switzerland

Department of Research, University Hospital Basel, Basel, Switzerland

Division of Hematology, University Hospital, Geneva, Switzerland

Division of Hematology, University Hospital, Department of Pathology-Immunology, University Medical Center, Geneva, Switzerland

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0301-472X(08)00004-0

doi:10.1016/j.exphem.2007.12.017

Experimental Hematology
Volume 36, Issue 5 , Pages 533-534, May 2008

Article Tools